Victory Capital Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $378K | Buy |
35,655
+1,353
| +4% | +$15.6K | ﹤0.01% | 2122 |
|
|
2026
Q1 | $350K | Sell |
34,302
-9,748
| -22% | -$105K | ﹤0.01% | 2098 |
|
|
2025
Q4 | $470K | Sell |
44,050
-19,364
| -31% | -$232K | ﹤0.01% | 2038 |
|
|
2025
Q3 | $867K | Buy |
+63,414
| New | +$886K | ﹤0.01% | 1913 |
|
|
2024
Q3 | – | Sell |
-35,973
| Closed | -$785K | – | 2508 |
|
|
2024
Q2 | $785K | Buy |
+35,973
| New | +$959K | ﹤0.01% | 1804 |
|
|
2024
Q1 | – | Sell |
-3,370
| Closed | -$227K | – | 2531 |
|
|
2023
Q4 | $227K | Sell |
3,370
-11,734
| -78% | -$817K | ﹤0.01% | 2200 |
|
|
2023
Q3 | $1.13M | Sell |
15,104
-65,203
| -81% | -$5.78M | ﹤0.01% | 1590 |
|
|
2023
Q2 | $7.4M | Sell |
80,307
-13,087
| -14% | -$1.17M | 0.01% | 1132 |
|
|
2023
Q1 | $9.68M | Buy |
93,394
+24,465
| +35% | +$2.71M | 0.01% | 1045 |
|
|
2022
Q4 | $7.95M | Sell |
68,929
-37,603
| -35% | -$4.38M | 0.01% | 1094 |
|
|
2022
Q3 | $11.5M | Sell |
106,532
-22,271
| -17% | -$3.19M | 0.01% | 1017 |
|
|
2022
Q2 | $23.3M | Buy |
128,803
+57,300
| +80% | +$10.3M | 0.03% | 763 |
|
|
2022
Q1 | $12.8M | Buy |
71,503
+48,231
| +207% | +$9.09M | 0.01% | 1030 |
|
|
2021
Q4 | $4.87M | Buy |
23,272
+3,447
| +17% | +$712K | ﹤0.01% | 1332 |
|
|
2021
Q3 | $3.82M | Buy |
19,825
+1,631
| +9% | +$401K | ﹤0.01% | 1400 |
|
|
2021
Q2 | $5.15M | Buy |
18,194
+3,713
| +26% | +$1.01M | ﹤0.01% | 1330 |
|
|
2021
Q1 | $3.07M | Sell |
14,481
-15,949
| -52% | -$3.82M | ﹤0.01% | 1512 |
|
|
2020
Q4 | $5.97M | Buy |
30,430
+5,682
| +23% | +$1M | 0.01% | 1194 |
|
|
2020
Q3 | $4.07M | Sell |
24,748
-421
| -2% | -$69.3K | 0.01% | 1238 |
|
|
2020
Q2 | $3.49M | Sell |
25,169
-1,804
| -7% | -$166K | ﹤0.01% | 1261 |
|
|
2020
Q1 | $1.69M | Buy |
26,973
+3,476
| +15% | +$316K | ﹤0.01% | 1393 |
|
|
2019
Q4 | $2.58M | Sell |
23,497
-87,662
| -79% | -$8.48M | ﹤0.01% | 1402 |
|
|
2019
Q3 | $11.5M | Buy |
111,159
+51,649
| +87% | +$5.55M | 0.01% | 942 |
|
|
2019
Q2 | $7.63M | Buy |
59,510
+58,090
| +4,091% | +$8.07M | 0.02% | 825 |
|
|
2019
Q1 | $181K | Buy |
1,420
+554
| +64% | +$70.3K | ﹤0.01% | 1593 |
|
|
2018
Q4 | $108K | Buy |
866
+34
| +4% | +$5.82K | ﹤0.01% | 1633 |
|
|
2018
Q3 | $184K | Sell |
832
-6,834
| -89% | -$1.39M | ﹤0.01% | 1604 |
|
|
2018
Q2 | $1.23M | Buy |
7,666
+153
| +2% | +$19.6K | ﹤0.01% | 1199 |
|
|
2018
Q1 | $702K | Sell |
7,513
-6,028
| -45% | -$450K | ﹤0.01% | 1304 |
|
|
2017
Q4 | $945K | Buy |
13,541
+821
| +6% | +$54.5K | ﹤0.01% | 1234 |
|
|
2017
Q3 | $755K | Sell |
12,720
-8,192
| -39% | -$408K | ﹤0.01% | 1271 |
|
|
2017
Q2 | $867K | Buy |
20,912
+1,563
| +8% | +$67.9K | ﹤0.01% | 1219 |
|
|
2017
Q1 | $859K | Buy |
+19,349
| New | +$833K | ﹤0.01% | 1213 |
|
Other funds holding MED
SCP
Victory Capital Management's MED Position: Q2 2026 in Review
Victory Capital Management increased its Medifast (MED) stake by 3.9% in Q2 2026, buying an estimated $15.6K and bringing the position to 35,655 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #2122.
Victory Capital Management first reported a position in MED in Q1 2017 and has held it in 33 quarters since. The position peaked at $23.3M in Q2 2022. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.
- Victory Capital Management held 35,655 shares of Medifast worth $378K as of Q2 2026.
- Victory Capital Management bought 1,353 Medifast shares in Q2 2026, an estimated $15.6K.
- Medifast made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2122 holding.
- Victory Capital Management first reported a position in Medifast in Q1 2017 and has held it in 33 quarters since.
- Victory Capital Management's Medifast position peaked at $23.3M in Q2 2022.
- 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.